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Abstract 
Phytochemical studies of the previously unexplored stem of Boerhavia erecta from Burkina Faso-
Africa, resulted in the isolation of an unreported glycoside 4, 2,3-dihydroxypropylbenzoate-3-O-β-[4''-
methoxy] glucuronide as well as seven known glycosides (1-3, 5-8). The major isolate 5 and 8 
indicated a significant inhibition against HIV-integrase (IC50 10 and 22 μg/mL, respectively). The 
extracts and isolates were also tested for anti-malarial activity but insignificant activity was observed.  
Keywords: African medicinal plant, Boerhavia erecta, Glycosides, Anti-HIV integrase activity, Anti-
malarial activity 
1. Introduction 
Burkina Faso is a country rich with medicinal plants including prospective medical sources of the 
Boerhavia erecta Linnaeus species which the aerial component of the plant is used in traditional 
medicine for the treatment of nervous malaria in infants, seizures in children, generalized edema, 
dyspnea, difficult delivery, hematuria, as an anti-convulsant, diuretic or spasmolytic (Hilou et al., 
2004). Previous studies on the extract of the leaves of B. erecta revealed some activities, including anti-
microbial (Perumal Samy et al., 1999) and anti-malarial effects (Hilou et al., 2004; Hilou et al., 2006; 
Stinzing et al., 2004). This led to the isolation of sterols and betanin (Stinzing et al., 2004; Miralles et 
al., 1988). The previous investigation was driven mainly by the isolation of phenolic compounds from 
the leaves of the plant for anti-oxidant studies (Petrus et al., 2012). Here, we report for the first time the 
results of the stem bark of this plant and the bioactive constituents of polar fraction of this plant.  
2. Result and discussion 
The non-polar alkanes and long chain fatty acids of the crude extract were removed by applying solid 
liquid (hexane, dichloromethane) back extraction. From the polar fraction, short normal phase column 
chromatography produced a major fraction which was subjected to preparative HPLC, isolating eight 
compounds (Figure 1): 3-methoxybenzoic acid 4-O-β-glucoside 1 (Liu et al., 2006), 3-
methoxyacetophenone 4-O-β-glucopyranoside 2 (Rosa et al., 1996), isorhamnetin-3-O-rutinoside-7-O-
β-glucopyranoside 3 (Aquino et al., 1987), quercetin-3-O-rutinoside 5, quercetin-3-O-β-
glucopyranoside 6, kaemferol-3-O-rutinoside 7 (Hamzah et al., 1998), and isorhamnetin-3-O-rutinoside 
8. Compounds 5, 6 and 8 were previously reported from the leaves of the plant (Petrus et al., 2012), and 
are spectroscopically identical to that reported. Importantly, compounds 1 – 3 and 7 were isolated from 
this plant for the first time in this study.  
 
R1=OH, R2=β-glucoside, 1 
R1=CH3, R2=β-glucoside, 2 
R1=OCH3, R2=rutinoside, R3= β-glucoside, 3 
R1=OH, R2=rutinoside, R3= H, 5 
R1=OH, R2=β-glucoside, R3= H, 6 
R1=H, R2=rutinoside, R3= H, 7 
R1=OCH3, R2=rutinoside, R3= H, 8 
Figure 1. Molecular structure of glycosides isolated from stem of Boerhavia erecta. Compound 9 was 
isolated from V. hookeriana (Maggi et. al, 2009). 
 
Additionally, for the previously unreported compound, we propose the structure 4 (Figure 2). The 
HRESI MS analysis of 4 indicated a peak at m/z 409.1107 ([M+Na]+), assigned to the molecular 
formula of C17H22O10Na. The NMR spectral analysis suggested a molecular structure which was 
similar to a reported glycerol α-D-glucuronide carboxylic acid (Cai et al., 2011) and its ester 9 (Maggi 
et. al, 2009). The 1H- and 13C-NMR spectral analysis indicated a singlet peak at δ 3.46 and δ 60.8 ppm, 
respectively, assigned to a methoxy group; this was in contrast to the corresponding ester OMe in 9 
with values assigned in the 1H- and 13C-NMR spectra of δ 3.66 and δ 52.8 ppm, respectively (Maggi et. 
al, 2009). This is particularly telling with the 8.0 ppm difference in the OMe in the 13C NMR spectrum, 
with the methoxy ester more upfield compared to the methoxy substituent, as expected. gHMBC 
spectral analysis of 4 indicated a proton-carbon correlation between the methoxy and carbon peak at δ 
83.0 (assigned to C4'' of the sugar moiety). Additionally, a 3-bond correlation between H4'' and the 
carbonyl was evident. Thus the molecular structure for 4 is proposed as 2,3-dihydroxypropyl-benzoate 
3-O-β-[4''-methoxy] glucuronide. The position of the benzoic ester carbonyl peak in the 13C NMR 
spectrum was consistent across all three derivatives (~168 ppm). 
 
 
Figure 2: Proposed structure of 4 and the known α-D-glucuronide carboxylates 9 and 10. Key NMR 
assignments are indicated (single-headed arrows) while key HMBC correlations (double-headed 
arrows) are also shown. For a larger set of correlations for 4, see SI. 
 
Preliminary studies on the crude extract revealed significant inhibition activity against HIV integrase in 
which ‘fraction B’ (the extract residue) showed a higher activity than the supernatant (fraction A). 
Further assays on the major constituents, compounds 5 and 8, indicated moderate and less activity 
compared to the original extract (Table 1). The isolates were also tested against P. falciparum K1 
which showed no significant activity (Table 1). The isolated compounds showed less inhibition relative 
to the fractions with the HIV integrase activity testing. This suggests a synergic mechanism playing an 
important role in the bioactivity. Fractions, sub-fractions, and compounds 1 - 8 were inactive against P. 
falciparum K1 (Table 1).  
 
Table 1. Anti-HIV integrase and anti-plasmodial activities (IC50 in μg/mL) of the extracts and pure 
compounds isolated from B. erecta 
Entry 
Anti-HIV integrase 
activity 
Anti-malarial activity 
IC50 (μg/mL) Activity IC50 (μg/mL) 
Crude extract < 1.6 na na 
Fraction A 16 inactive - 
Fraction B < 0.4 inactive - 
Fraction B1 < 10 na na 
Fraction B2 < 46 na na 
Fraction B4 > 50 na na 
5 < 10 inactive - 
8 < 22 inactive - 
Note: na: data not available. -: No activity. Compounds 1-4, 6 and 7 were inactive against P. falciparum K1 and were not 
tested against HIV integrase. Anti-malarial testing, final conc. of samples: 10 μg/mL Negative control: 0.1% DMSO. IC50 of 
positive control: Dihydroartemisinine = 2.20 nM, Mefloquine = 0.0310 μM. 
Quercetin has been reported to inhibit HIV infected cells (Tang et al., 1994), which were later found to 
have diverse modes of action including anti-protease (PR), anti-integrase (IN) and anti-transcriptase 
(RT) activities. Quercetin and rutin revealed inhibition against HIV-1 protease with IC50 values of 34 
and 28 µg/mL, respectively, although methoxylation or glucosylation at 3,7,4' reduced its activity (Xu 
et al., 2000). Quercetin was a weak HIV-1 RT inhibitor (IC50 150-200 µg/mL) possibly due to 
structural planarity which weakens its intercalating properties (Tan et al., 1991) however, glucosylation 
at 3' increased the activity (IC50 15 µg/mL). Quercetin possessed anti-integrase activity with IC50 of 4 
µg/mL) (Raghavan et al., 1995). 
 
3. Conclusions 
A previously unreported derivative of the glycerol α-D-glucuronide class of compounds (4) was 
isolated from the stem of B. erecta which was proposed as 2,3-dihydroxypropylbenzoate 3-O-β-[4''-
methoxy] glucuronide. Moderate anti-HIV integrase activity was shown the by major constituents (5 
and 8). The anti-malarial testing against P. falciparum K1 indicated none of the purified compounds 
possessed anti-plasmodial activity. However, the major compounds 5 and 8 were previously reported to 
have anti-malarial activity P. falciparum (FCR3, cycloguanil-resistant from Gambia) (Murakami et al., 
2001). Therefore, these compounds show significant differences in their P. falciparum inhibitory 
activity between different strains. 
 
Supplementary data: Experimental details relating to this article are available online; 1H, 13C, COSY, 
gTOCSY, HSQC, HMBC, HR ESI MS and MS/MS spectra of compounds 4. 
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